Literature DB >> 3199593

In vitro effect of beta-lactam antibiotics and N-methyltetrazolethiol on microsomal vitamin K epoxide reductase in rats.

K Kawamoto1, A Touchi, K Sugeno, T Matsubara.   

Abstract

Liver microsomal vitamin K epoxide reductase activity was determined by measuring the formation of menaquinone-4 from the substrate menaquinone-4 2,3-epoxide. The enzyme was active when dithiothreitol (DTT) was used as a reducing agent, and the activity increased gradually with increasing concentrations of DTT. Glutathione and cysteine also functioned as reductants, but these physiological reductants showed less than 15% of the activity detected with 0.5 mM DTT. Addition of various beta-lactam antibiotics to the assay mixture for vitamin K epoxide reductase caused a slight inhibition of the activity. N-Methyltetrazolethiol (NMTT) and other heterocyclic thiol compounds also inhibited the enzyme activity in vitro depending on their concentrations. Most of these antibiotics and heterocyclic thiol compounds inhibited the enzyme activity only 10-25% in the in vitro assay system even when higher concentrations were added (5-10 mM). Among the compounds tested, methyl-thiadiazolethiol was the only compound that caused 50% inhibition of the enzyme activity. NMTT-induced inhibition was diminished gradually by increasing DTT concentrations. Kinetic analysis of the inhibitory action of heterocyclic thiol compounds showed competitive inhibition against the reductant DTT and non-competitive inhibition against the substrate. On the other hand, warfarin, a typical anticoagulant, showed different patterns in the inhibitory action: non-competitive inhibition against DTT and mixed-type inhibition against the substrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199593     DOI: 10.1254/jjp.47.169

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial.

Authors:  Qian Zhang; Guy Simoneau; Celine Verstuyft; Ludovic Drouet; Claire Bal dit Sollier; Jean-Claude Alvarez; Nathalie Rizzo-Padoin; Jean Francois Bergmann; Laurent Becquemont; Stéphane Mouly
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  Effect of flomoxef on blood coagulation and alcohol metabolism.

Authors:  K Uchida; T Matsubara
Journal:  Infection       Date:  1991       Impact factor: 3.553

3.  Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

Authors:  A Kotsiou; E Diamanti; A Potamianou; H Parara; J Vovou; C Perisanidis; C Tes; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.